🔎 Trials Near Me

Akèy › Leiomyosarkom › Texas › Houston

Etid klinik pou Leiomyosarkom nan Houston, TX

7 etid pou Leiomyosarkom ap chèche patisipan nan sit nan ak bò kote Houston (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Testing the Addition of an Anti-cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (Gemcitabine) for Soft Tissue Sarcoma

Ap rekriteFaz 1/2
  • UT MD Anderson Cancer Center, Houston
Laj 18 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT06498648

Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma

Ap rekriteFaz 3
  • M D Anderson Cancer Center, Houston
Laj 18 ak plis · Tout sèks · Mizajou Sep 10, 2026 · NCT04031677

Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma

Ap rekriteFaz 1
  • UT MD Anderson Cancer Center, Houston
Laj 18 ak plis · Tout sèks · Mizajou Sep 4, 2026 · NCT05711615

STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers and as Monotherapy in Participants With Selected Sarcomas

Ap rekriteFaz 1/2
  • MD Anderson Cancer Center, Houston
  • NEXT Houston, Houston
Laj 18 ak plis · Tout sèks · Mizajou Aug 25, 2026 · NCT06975293

A Phase 1b, Open-Label Study Of REC-617, A Selective CDK7 Inhibitor, In Patients With Metastatic Or Unresectable RB1-Negative Leiomyosarcoma After Prior Systemic Therapy

Ap rekriteFaz 1
  • MD Anderson Cancer Center, Houston
Laj 18 ak plis · Tout sèks · Mizajou Jul 31, 2026 · NCT07633756

Metastatic Leiomyosarcoma Biomarker Protocol

Ap rekriteEtid obsèvasyon
  • MD Anderson, Houston
Tout laj · Tout sèks · Mizajou Jun 24, 2026 · NCT05653388

A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors

Ap rekriteFaz 1
  • MD Anderson Cancer Center, Houston
Laj 18 ak plis · Tout sèks · Mizajou Jun 11, 2026 · NCT06789172

Etid Leiomyosarkom nan lòt vil

Lòt etid nan Houston

Sous ClinicalTrials.gov, done yo ranmase Oct 3, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.